Kyntra Bio, Inc. (NASDAQ: KYNB) Q1 2026 Earnings Call Transcript May 11, 2026 Kyntra Bio, Inc. misses on earnings expectations. Reported EPS is $-3.76 EPS, expectations were $-3.36.

The EVERY Co accuses Onego Bio and its lawyers of violating federal rules designed to prevent frivolous or abusive litigation ...

Austin,TX , Sensor Bio, the continuous biometric signal infrastructure platform built for clinical, enterprise, and AI ...

Bio-Techne Corporation ( TECH) Q3 2026 Earnings Call May 6, 2026 9:00 AM EDT Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Third Quarter and Fiscal Year 2026. [Operator ...

A small model with a visual feedback loopAt the core of the system is Bioinspired3D, a 3-billion-parameter language model fine-tuned on a curated ...

Author Brian Jay Jones discusses writing Jim Henson’s biography, from the Muppets to filmmaking, TV innovation and Henson's ...

Good afternoon, everyone, and thank you for joining us today to discuss Kyntra Bio, Inc.’s first quarter 2026 financial and business results. I am Gaia Vasiliver-Shamis from LifeSci Advisors. Joining ...

Mission Bio, the single-cell multi-omics leader, today released data showing that its Targeted Single-Cell DNA+RNA Assay ...

Company to Host Conference Call Today, May 7th, at 4:30pm ETBOCA RATON, Fla., May 07, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company ...

“We can learn from dogs as much as they learn from us.” ...

Chronic wasting disease reaches National Elk Refuge, invigorating plan to review Scouts’ elk antler auction and other ...

He was an early investor in Uber, Zillow, and Nextdoor. Those successes helped turn Benchmark, the VC firm where he’s general ...